1. Home
  2. Companies
  3. MediciNova
  4. Financial Statements
  5. Income Statement
  6. Operating Expenses
MediciNova logo
MediciNova MNOV
$ 1.44 1.41%

Annual report 2025
added 03-10-2026

report update icon

MediciNova Operating Expenses 2011-2026 | MNOV

Annual Operating Expenses MediciNova

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
13.7 M 12.7 M 10.9 M 14.6 M 14.3 M 14.2 M 14 M 15.6 M 13 M 10.9 M 8.82 M 9.22 M 10 M 11.7 M 16.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
16.1 M 8.82 M 12.7 M

Quarterly Operating Expenses MediciNova

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.5 M 3.74 M 3.2 M - 3.31 M 3.05 M 3.14 M - 2.15 M 3.3 M 2.96 M - 3.9 M 4.09 M 3.41 M - 3.64 M 4.31 M 4.2 M - 3.73 M 4.51 M 2.92 M - 2.65 M 4.18 M 4.98 M 492 K 7.03 M 3.4 M 4.67 M 3.41 M 3.79 M 2.8 M 3.02 M 1.44 K 2.84 K 3.2 K 3.39 K 2.74 K 1.59 K 2.28 K 2.22 K 2.38 K 2.34 K 2.13 K 2.36 K 2.57 M 2.24 M 2.79 M 2.42 M 2.46 M 2.45 M 2.78 M 4.06 M 3.5 M 3.91 M 3.72 M 4.98 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.03 M 1.44 K 2.67 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
 		432 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
 		206 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		140 M - - $ 86.2 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		708 M $ 22.56 2.13 % $ 3.74 B usaUSA
AlloVir AlloVir
ALVR
 		46.2 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		127 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		74.5 M - - $ 8.42 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		173 M $ 1.43 3.62 % $ 368 M usaUSA
argenx SE argenx SE
ARGX
 		3.19 B $ 785.07 2.57 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
 		1.49 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		2.66 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		78.3 M - 2.54 % $ 160 B franceFrance
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
 		1.13 B $ 327.25 2.42 % $ 42.9 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		53.7 M $ 2.66 3.5 % $ 16.7 M usaUSA
AVROBIO AVROBIO
AVRO
 		71.7 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		29.8 M - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
 		17.6 B - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
 		4.78 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		8.22 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		390 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		16.7 M $ 3.9 3.7 % $ 9.38 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		133 M - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
 		22 M - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		216 M $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		85.5 M $ 4.18 1.21 % $ 447 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		26 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		177 M - - $ 1.41 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		629 M - - - russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		137 M $ 24.61 5.76 % $ 3.13 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
 		172 M $ 3.09 0.65 % $ 310 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		56.2 M - - $ 169 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		23 M - 5.93 % $ 314 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		61.5 M - - $ 231 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		24.2 M - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		110 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		210 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		66.5 M - - $ 26.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		145 M $ 1.49 9.56 % $ 397 M britainBritain
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		47.8 M - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		179 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		24.7 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		9.17 M - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		226 M - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		80.2 M - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		137 M - - $ 2.02 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
 		70.7 M $ 26.27 0.38 % $ 340 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		88.9 M - - $ 867 M germanyGermany
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
 		17.3 M $ 3.88 2.11 % $ 261 B britainBritain
Akouos Akouos
AKUS
 		86.8 M - 0.23 % $ 488 M usaUSA